| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5686677 | The Journal of Urology | 2017 | 33 Pages |
Abstract
We found that α1-blocker withdrawal from combination therapy was reasonable and tolerable with regard to the effect on lower urinary tract symptoms and bladder outlet obstruction. However, withdrawal must be performed carefully in patients with a high body mass index.
Keywords
PdetQmax5ARIQmaxLUTS/BPHOveractive bladder symptom scoreUDSSMART-1I-PSSBOOIOABSSQOLPSAQuality of lifeAdrenergic alpha-antagonistsProstate specific antigenBladder outlet obstructionurinary bladder neck obstructionBOODrug substitutionpost-void residual urine volumemaximum urinary flow ratebody mass indexBMIPVRLower urinary tract symptomsCombatUrodynamic study5-Alpha reductase inhibitors5α-reductase inhibitorLUTSInternational Prostate Symptom Score
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Yoshihisa Matsukawa, Shun Takai, Yasuhito Funahashi, Tsuyoshi Majima, Masashi Kato, Tokunori Yamamoto, Momokazu Gotoh,